New Therapy Kills Human Leukemia Cel... (d ALL cell lines and patient leukemia bl...)

(Date:11/21/2009)... Innovative medical apparel company launche... San Clemente, Calif. (PRWEB) ...through medical apparel, today announced the launc...Medica 2009, a leading international trade fair fo.... Medelita inaugurates its men,s collection with t...

(Date:11/21/2009)... New Haven Dental Group merges their practi...rd, CT. , (PRWEB) Novembe...d of partners Dr. David Gibson, Dr. Dean Cloutier,...ust merged their growing practice with that of est.... Pickman decided he wanted to retire from dentist...

(Date:11/20/2009)...TON, NJ, Nov. 20 /PRNewswire-FirstCall/ - NUCRYST ...al Meeting of Shareholders will be held on Monday,...to consider approval of two special resolutions. T...orize the sale of all or substantially all of the ...ided for in the asset purchase agreement dated Nov...

(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...

(Date:11/20/2009)..., Nov. 20 The American ... and Drug Administration (FDA) to establish approp...s. ,, Citing concern about the safety of white...the benefit of professional consultation or examin...application of chemically based tooth whitening or...

Breaking Medicine News(10 mins):Health News:Medelita Introduces Men's Lab Coat Collection 2 Health News:Medelita Introduces Men's Lab Coat Collection 3 Health News:New Haven Dental Group Expands Their Vision 2 Health News:NUCRYST Announces Special Meeting of Shareholders 2 Health News:NUCRYST Announces Special Meeting of Shareholders 3 Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2 Health News:American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products 2

[0] Medelita Introduces Men's Lab Coat Collection [0] New Haven Dental Group Expands Their Vision [0] NUCRYST Announces Special Meeting of Shareholders [0] Stop & Shop Alerts Customers to Voluntary Recall by Unilever [0] American Dental Association Petitions FDA to Classify, Regulate Tooth-Whitening Products

... Today, the Center for Reproductive Rights issued ...ion provider Dr. George Tiller. Dr. Tiller was mur...ne of the few physicians in the country who provid...ghts represented two-thousand of Dr. Tiller,s pati...

... 2009)Fox Chase Cancer Center investigators report...s safe in metastatic kidney cancer in a phase I tr...sirolimus and bryostatin may be active in patients...ogist and attending physician at Fox Chase will re...

...s efficacy against malignancies that don,t respond...Day News) -- Using a combination of the drugs tems...fe in patients with metastatic kidney cancer, acco...d tumor blood vessel development. The temsirolimus...

...aVita Inc. (NYSE: DVA ), a leading provider of k...ic kidney disease (CKD), today announced the DaVit...the Apple iPhone and iPod Touch has been downloade...of countries where the application has been downlo...

..., May 31 Impac Software, part of the Elekta Group...r of the Year award to Deanna Derdelinghen, Cert...l,s Bennett Cancer Center in Stamford, Connecticut...d extend their contributions to benefit the broade...

...ccuracy of standard PSA test, study shows , ... test greatly reduces false-positive results in pr...tion with a prostate-specific antigen (PSA) test, ... test accurately detected prostate cancer more tha...

Center for Reproductive Rights Deeply Saddened by Murder of Dr. George Tiller 2-drug combination appears safe and active in metastatic kidney cancer Two Drugs Safe for Rare Forms of Kidney Cancer DaVita's Kidney Calculator iPhone App Downloaded in 24 Countries Impac Software Selects 2009 Cancer Registrar of the Year Gene Test Helps Detect Prostate Cancer

(Date:11/19/2009)...-- In response to an ever-increasing number of web...peration Pangea II, involving 24 countries, was co...ation,s International Medical Products Anti-Counte...rs of buying medicines online. ,, The week long... and the seizure of thousands of potentially harmf...

(Date:11/19/2009)...ewswire-FirstCall/ -- Alexza Pharmaceuticals, Inc....te presentation will be webcast live during the 21...Wednesday, December 2, 2009 at 9:00 a.m. Eastern T...w York Palace Hotel in New York and will be presen... ,, To access the live presentation via the Web...

(Date:11/19/2009)...wire/ -- Ligon Discovery, Inc., which uses proprie...drugs against high-value targets, today announced ...cTANK Ventures. The company will use the capital t...l screen over 100 high-value disease protein targe... Partner Christian Bailey joins the board. ,, P...

Breaking Medicine Technology:International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2 Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2 Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3 Cambridge-based Ligon Discovery Raises $1M in Seed Funding 2 Cambridge-based Ligon Discovery Raises $1M in Seed Funding 3 Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 1 Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 2 Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 3 Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 4 Community Oncologists and Patients Stand Up for Cancer Care on Capitol Hill 51047 5 Hip Arthroscopy Procedures to Soar Through 2013 51045 1 Hip Arthroscopy Procedures to Soar Through 2013 51045 2 DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 1 DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 2 DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 3 DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 4 DOR BioPharma Announces Issuance of European Patent for its LPM 28TM 29 Oral Drug Delivery Technology 12934 5

[0] International Operation Combats Online Supply of Counterfeit and Illegal Medicines [0] Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference [0] Cambridge-based Ligon Discovery Raises $1M in Seed Funding

... Phase 1/2 Trial of TRU-016, Trubion,s Proprietary...I-087 for RA Expands Trubion,s Family of Customize...t Candidates, SEATTLE, March 27 Trubion Pharmace... it has initiated a Phase 1/2,clinical trial of TR...r,ImmunoPharmaceutical (SMIP(TM)) drug candidate, ...

...ng Therapeutic Value of Cord Blood Stem Cells, OL...bilical cord blood are showing early potential in ... from a new preclinical study,published in the Mar...conducted by researchers from the University of So...ound that targeted immune suppression using stem,c...

Other Medicine Technology:Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 2 Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 3 Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 4 Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update 5 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 2 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 3 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 4 Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease 5

Trubion Initiates Phase 1/2 Study of TRU-016 in CLL, Announces Next-Generation Product Candidate for RA and Provides Product Pipeline Update Early Research Suggests Umbilical Cord Blood Cell Therapy May Reduce Progression of Alzheimer's Disease

... national reference laboratory and a worldwide lea...ent. ARUP offers an extensive test menu of highly ...natomic pathology. Owned by the University of Utah...f of the nation's university teaching hospitals an...

Medicine Products:

Lymphocyte Subset Panel 7-Congenital Immunodeficiencies Lymphocyte Transplantation Profile Lymphocyte Subset Panel 5-Total Lymphocyte Enumeration Lymphocyte Subset Panel 1-CD4 Absolute Count Only

New Therapy Kills Human Leukemia Cel...(d ALL cell lines and patient leukemia bl...),Health